-
Responding to existential distress at the end of life: Psychedelics and psychedelic experiences and/ as medicine Neuroethics (IF 2.6) Pub Date : 2024-08-24 Nathan Emmerich
This essay engages with the (re)emergence of psychedelic medicine and the idea of psychedelics drugs and the experiences they induce as a developing therapeutic modality. It does so in the context of the provision of psychedelics to terminally ill patients experiencing existential distress as they approach the end of their lives. Reflecting on such suggestions facilitates an examination of a specific
-
Deep Brain Stimulation for Consciousness Disorders; Technical and Ethical Considerations Neuroethics (IF 2.6) Pub Date : 2024-07-30 Alceste Deli, Alexander L. Green
Disorders of Consciousness (DoC) result in profound functional impairment, adversely affecting the lives of a predominantly younger patient population. Currently, effective treatment options for those who have reached chronicity (prolonged symptom duration over 4 weeks) are extremely limited, with the majority of such cases facing life-long dependence on carers and a poor quality of life. Here we briefly
-
Neurorights, Mental Privacy, and Mind Reading Neuroethics (IF 2.6) Pub Date : 2024-07-09 Cohen Marcus Lionel Brown
A pressing worry in the ongoing neurorights debate is the language used to advocate for newly proposed rights. This paper addresses this concern by first examining the partial and ambiguous associations between mind reading and neurotechnology, often cited by advocates in support of the right to mental privacy. Secondly, it addresses the conceptual foundations of mind reading, distinguishing between
-
A Transformative Trip? Experiences of Psychedelic Use Neuroethics (IF 2.6) Pub Date : 2024-06-20 Logan Neitzke-Spruill, Caroline Beit, Jill Robinson, Kai Blevins, Joel Reynolds, Nicholas G. Evans, Amy L. McGuire
Psychedelic experiences are often compared to “transformative experiences” due to their potential to change how people think and behave. This study empirically examines whether psychedelic experiences constitute transformative experiences. Given psychedelics’ prospective applications as treatments for mental health disorders, this study also explores neuroethical issues raised by the possibility of
-
The Reliability Challenge to Moral Intuitions Neuroethics (IF 2.6) Pub Date : 2024-06-08 Dario Cecchini
In recent years, the epistemic reliability of moral intuitions has been undermined by substantial empirical data reporting the influence of cognitive biases. This paper discusses and elaborates upon a promising strategy in response to the reliability challenge to moral intuitions. The considered argument appeals to the fact that moral intuitions are experienced with different levels of strength and
-
Neurotechnological Applications and the Protection of Mental Privacy: An Assessment of Risks Neuroethics (IF 2.6) Pub Date : 2024-05-29 Pablo López-Silva, Abel Wajnerman-Paz, Fruzsina Molnar-Gabor
The concept of mental privacy can be defined as the principle that subjects should have control over the access to their own neural data and to the information about the mental processes and states that can be obtained by analyzing it. Our aim is to contribute to the current debate on mental privacy by identifying the main positions, articulating key assumptions and addressing central arguments. First
-
When Do People Have an Obligation Not to Tic? Blame, Free Will, and Moral Character Judgments of People with Tourette’s Syndrome Neuroethics (IF 2.6) Pub Date : 2024-05-23 Joseph Masotti, Paul Conway
-
Literary Neuroexistentialism: Coming to Terms with Materialism and Finding Meaning in the Age of Neuroscience through Literature Neuroethics (IF 2.6) Pub Date : 2024-05-21 Mette Leonard Høeg
With the rise of the scientific authority of neuroscience and recent neurotechnological advances, the understanding of the human being and its future is beginning to undergo a radical change. As a result, a normative and existential vacuum is opening and hopes as well as fears about the future are flourishing. Some philosophers are anticipating a broad neuroscientific disenchantment, sociocultural
-
The Ethical Implications of Illusionism Neuroethics (IF 2.6) Pub Date : 2024-05-20 Keith Frankish
Illusionism is a revisionary view of consciousness, which denies the existence of the phenomenal properties traditionally thought to render experience conscious. The view has theoretical attractions, but some think it also has objectionable ethical implications. They take illusionists to be denying the existence of consciousness itself, or at least of the thing that gives consciousness its ethical
-
How Do Psychedelics Reduce Fear of Death? Neuroethics (IF 2.6) Pub Date : 2024-05-17 Chris Letheby
Increasing evidence suggests that psychedelic experiences, undergone in controlled conditions, can have various durable psychological benefits. One such benefit is reductions in fear of death, which have been attested in both psychiatric patients and healthy people. This paper addresses the question: how, exactly, do psychedelic experiences reduce fear of death? It argues, against some prominent proposals
-
Who does Neuroethics Scholarship Address, and What Does it Recommend? A Content Analysis of Selected Abstracts from the International Neuroethics Society Annual Meetings Neuroethics (IF 2.6) Pub Date : 2024-05-14 Nina Yichen Wei, Rebekah J. Choi, Laura Specker Sullivan, Anna Wexler
-
Autism and the Case Against Job Interviews Neuroethics (IF 2.6) Pub Date : 2024-05-13 Bouke de Vries
Unemployment rates among autistic people are high even among those with low-support needs. While a variety of measures is needed to address this problem, this article defends one that has not been defended in detail and that has profound implications for contemporary hiring practices. Building on empirical research showing that job interviews are a major contributor to autistic unemployment, it argues
-
Perceptions on the Ethical and Legal Principles that Influence Global Brain Data Governance Neuroethics (IF 2.6) Pub Date : 2024-05-06 Paschal Ochang, Damian Eke, Bernd Carsten Stahl
-
What Happens After a Neural Implant Study? Neuroethics Expert Workshop on Post-Trial Obligations Neuroethics (IF 2.6) Pub Date : 2024-04-29 Ishan Dasgupta, Eran Klein, Laura Y. Cabrera, Winston Chiong, Ashley Feinsinger, Joseph J. Fins, Tobias Haeusermann, Saskia Hendriks, Gabriel Lázaro-Muñoz, Cynthia Kubu, Helen Mayberg, Khara Ramos, Adina Roskies, Lauren Sankary, Ashley Walton, Alik S. Widge, Sara Goering
What happens at the end of a clinical trial for an investigational neural implant? It may be surprising to learn how difficult it is to answer this question. While new trials are initiated with increasing regularity, relatively little consensus exists on how best to conduct them, and even less on how to ethically end them. The landscape of recent neural implant trials demonstrates wide variability
-
Consciousness Ain’t All That Neuroethics (IF 2.6) Pub Date : 2024-04-24 Neil Levy
Most philosophers think that phenomenal consciousness underlies, or at any rate makes a large contribution, to moral considerability. This paper argues that many such accounts invoke question-begging arguments. Moreover, they’re unable to explain apparent differences in moral status across and within different species. In the light of these problems, I argue that we ought to take very seriously a view
-
Human Brain Organoid Transplantation: Testing the Foundations of Animal Research Ethics Neuroethics (IF 2.6) Pub Date : 2024-04-17 Alexandre Erler
Alongside in vitro studies, researchers are increasingly exploring the transplantation of human brain organoids (HBOs) into non-human animals to study brain development, disease, and repair. This paper focuses on ethical issues raised by such transplantation studies. In particular, it investigates the possibility that they might yield enhanced brain function in recipient animals (especially non-human
-
Stream of Consciousness: Some Propositions and Reflections Neuroethics (IF 2.6) Pub Date : 2024-04-11 Nicholas Royle
This short communication explores the idea of “stream of consciousness” and considers some of the ways in which scientific writing relies – even or perhaps especially insofar as it does not signal this fact – on the resources of literary language and literary thinking. Particular attention is given to notions of literal and figurative or metaphorical language, including “hydrological” and “ontic” metaphor
-
“You shall have the thought”: habeas cogitationem as a New Legal Remedy to Enforce Freedom of Thinking and Neurorights Neuroethics (IF 2.6) Pub Date : 2024-04-04 José M. Muñoz, José Ángel Marinaro
Despite its obvious advantages, the disruptive development of neurotechnology can pose risks to fundamental freedoms. In the context of such concerns, proposals have emerged in recent years either to design human rights de novo or to update the existing ones. These new rights in the age of neurotechnology are now widely referred to as “neurorights.” In parallel, there is a considerable amount of ongoing
-
Revisiting Maher’s One-Factor Theory of Delusion, Again Neuroethics (IF 2.6) Pub Date : 2024-04-03 Ema Sullivan-Bissett, Paul Noordhof
Chenwei Nie ([22]) argues against a Maherian one-factor approach to explaining delusion. We argue that his objections fail. They are largely based on a mistaken understanding of the approach (as committed to the claim that anomalous experience is sufficient for delusion). Where they are not so based, they instead rest on misinterpretation of recent defences of the position, and an underestimation of
-
Health Aspirations for Transcranial Direct Current Stimulation (tDCS) Neuroethics (IF 2.6) Pub Date : 2024-03-28 Sophie Sargent, Judy Illes
Advances in neuroscience have enabled the transition of transcranial direct current stimulation (tDCS) from research and clinical settings to public use. For this primarily home-based context, tDCS has been popularized as a do-it-yourself (DIY) approach to improved cognition and wellness. The line between wellness and health is blurry, however, and little is known about how engagement with therapeutic
-
The Psychological Process Underlying Attitudes Toward Human-Animal Chimeric Brain Research: An Empirical Investigation Neuroethics (IF 2.6) Pub Date : 2024-03-26 Tetsushi Tanibe, Takumi Watanabe, Mineki Oguchi, Kazuki Iijima, Koji Ota
-
Psychedelic Therapy as Form of Life Neuroethics (IF 2.6) Pub Date : 2024-03-16 Nicolas Langlitz, Alex K. Gearin
In the historical context of a crisis in biological psychiatry, psychedelic drugs paired with psychotherapy are globally re-emerging in research clinics as a potential transdiagnostic therapy for treating mood disorders, addictions, and other forms of psychological distress. The treatments are poised to soon shift from clinical trials to widespread service delivery in places like Australia, North America
-
The Case Against Organoid Consciousness Neuroethics (IF 2.6) Pub Date : 2024-03-14 James Croxford, Tim Bayne
Neural organoids are laboratory-generated entities that replicate certain structural and functional features of the human brain. Most neural organoids are disembodied—completely decoupled from sensory input and motor output. As such, questions about their potential capacity for consciousness are exceptionally difficult to answer. While not disputing the need for caution regarding certain neural organoid
-
Ethical Implications of the Impact of Fracking on Brain Health Neuroethics (IF 2.6) Pub Date : 2024-02-28 Ava Grier, Judy Illes
-
Giving Consent to the Ineffable Neuroethics (IF 2.6) Pub Date : 2024-02-15 Daniel Villiger
A psychedelic renaissance is currently taking place in mental healthcare. The number of psychedelic-assisted therapy trials is growing steadily, and some countries already grant psychiatrists special permission to use psychedelics in non-research contexts under certain conditions. These clinical advances must be accompanied by ethical inquiry. One pressing ethical question involves whether patients
-
Safeguarding Users of Consumer Mental Health Apps in Research and Product Improvement Studies: an Interview Study Neuroethics (IF 2.6) Pub Date : 2024-01-29 Kamiel Verbeke, Charu Jain, Ambra Shpendi, Pascal Borry
Mental health-related data generated by app users during the routine use of Consumer Mental Health Apps (CMHAs) are being increasingly leveraged for research and product improvement studies. However, it remains unclear which ethical safeguards and practices should be implemented by researchers and app developers to protect users during these studies, and concerns have been raised over their current
-
Global Versus Local Theories of Consciousness and the Consciousness Assessment Issue in Brain Organoids Neuroethics (IF 2.6) Pub Date : 2024-01-27 Maxence Gaillard
Any attempt at consciousness assessment in organoids requires careful consideration of the theory of consciousness that researchers will rely on when performing this task. In cognitive neuroscience and the clinic, there are tools and theories used to detect and measure consciousness, typically in human beings, but none of them is neither fully consensual nor fit for the biological characteristics of
-
Rewriting the Script: the Need for Effective Education to Address Racial Disparities in Transcranial Magnetic Stimulation Uptake in BIPOC Communities Neuroethics (IF 2.6) Pub Date : 2024-01-27 Christi R. P. Sullivan, Alex Henry, Jonathan Lehman, Logan Caola, Ziad Nahas, Alik S. Widge, Laura Y. Cabrera, Anita Randolph, Saydra Wilson
-
Patentability of Brain Organoids derived from iPSC– A Legal Evaluation with Interdisciplinary Aspects Neuroethics (IF 2.6) Pub Date : 2024-01-18 Hannes Wolff
Brain Organoids in their current state of development are patentable. Future brain organoids may face some challenges in this regard, which I address in this contribution. Brain organoids unproblematically fulfil the general prerequisites of patentability set forth in Art. 3 (1) EU-Directive 98/44/EC (invention, novelty, inventive step and susceptibility of industrial application). Patentability is
-
What (if anything) morally separates environmental from neurochemical behavioral interventions? Neuroethics (IF 2.6) Pub Date : 2023-12-22 Viktor Ivanković
Drawing from the literatures on the ethics of nudging and moral bioenhancement, I elaborate several pairs of cases in which one intervention is classified as an environmental behavioral intervention (EBI) and the other as a neurochemical behavioral intervention (NBI) in order to morally compare them. The intuition held by most is that NBIs are by far the more morally troubling kind of influence. However
-
Dimensions of Consciousness and the Moral Status of Brain Organoids Neuroethics (IF 2.6) Pub Date : 2023-11-22 J. Lomax Boyd, Nethanel Lipshitz
Human brain organoids (HBOs) are novel entities that may exhibit unique forms of cognitive potential. What moral status, if any, do they have? Several authors propose that consciousness may hold the answer to this question. Others identify various kinds of consciousness as crucially important for moral consideration, while leaving open the challenge of determining whether HBOs have them. This paper
-
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research Neuroethics (IF 2.6) Pub Date : 2023-11-06 Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, David Nutt, Meg J. Spriggs
The ethical value—and to some scholars, necessity—of providing trial patients with post-trial access (PTA) to an investigational drug has been subject to significant attention in the field of research ethics. Although no consensus has emerged, it seems clear that, in some trial contexts, various factors make PTA particularly appropriate. We outline the atypical aspects of psychedelic clinical trials
-
Rationales and Approaches to Protecting Brain Data: a Scoping Review Neuroethics (IF 2.6) Pub Date : 2023-11-04 Anita S. Jwa, Nicole Martinez-Martin
-
How to Advance the Debate on the Criminal Responsibility of Antisocial Offenders Neuroethics (IF 2.6) Pub Date : 2023-10-21 Marko Jurjako, Luca Malatesti, Inti A. Brazil
-
The Ethics of Human Brain Organoid Transplantation in Animals Neuroethics (IF 2.6) Pub Date : 2023-10-04 Masanori Kataoka, Christopher Gyngell, Julian Savulescu, Tsutomu Sawai
-
Neurointerventions in Criminal Justice: On the Scope of the Moral Right to Bodily Integrity Neuroethics (IF 2.6) Pub Date : 2023-09-27 V. Tesink, T. Douglas, L. Forsberg, S. Ligthart, G. Meynen
There is growing interest in the use of neurointerventions to reduce the risk that criminal offenders will reoffend. Commentators have raised several ethical concerns regarding this practice. One prominent concern is that, when imposed without the offender’s valid consent, neurointerventions might infringe offenders’ right to bodily integrity. While it is commonly held that we possess a moral right
-
Brain age Prediction and the Challenge of Biological Concepts of Aging Neuroethics (IF 2.6) Pub Date : 2023-09-23 Jan-Hendrik Heinrichs
Brain age prediction is a relatively new tool in neuro-medicine and the neurosciences. In research and clinical practice, it finds multiple use as a marker for biological age, for general health status of the brain and as an indicator for several brain-based disorders. Its utility in all these tasks depends on detecting outliers and thus failing to correctly predict chronological age. The indicative
-
Addiction and Volitional Abilities: Stakeholders’ Understandings and their Ethical and Practical Implications Neuroethics (IF 2.6) Pub Date : 2023-09-21 Marianne Rochette, Matthew Valiquette, Claudia Barned, Eric Racine
Addiction is a common condition affecting millions of people worldwide of which only a small proportion receives treatment. The development and use of healthcare services is influenced by how addiction is understood (e.g., a condition to treat, a shameful condition to stigmatize), notably with respect to how volition is impacted (e.g., addiction as a choice or a disease beyond one’s control). Through
-
Potential Consciousness of Human Cerebral Organoids: on Similarity-Based Views in Precautionary Discourse Neuroethics (IF 2.6) Pub Date : 2023-09-18 Sarah Diner
Advances in research on human cerebral organoids (HCOs) call for a critical review of current research policies. A challenge for the evaluation of necessary research regulations lies in the severe uncertainty about future trajectories the currently very rudimentary stages of neural cell cultures might take as the technology progresses. To gain insights into organotypic cultures, ethicists, legal scholars
-
Why Won’t You Listen To Me? Predictive Neurotechnology and Epistemic Authority Neuroethics (IF 2.6) Pub Date : 2023-08-24 Alessio Tacca, Frederic Gilbert
From epileptic seizures to depressive symptoms, predictive neurotechnologies are used for a large range of applications. In this article we focus on advisory devices; namely, predictive neurotechnology programmed to detect specific neural events (e.g., epileptic seizure) and advise users to take necessary steps to reduce or avoid the impact of the forecasted neuroevent. Receiving advise from a predictive
-
Should Moral Bioenhancement Be Covert? A Response to Crutchfield Neuroethics (IF 2.6) Pub Date : 2023-08-22 Louis Austin-Eames
Crutchfield (Crutchfield in Bioethics 33:112–121, [4]) has argued that if moral bioenhancement (MBE) ought to be compulsory, then it ought to be covert. More precisely, they argue that MBE is a public health intervention, and for this reason should be governed by public health ethics. Taking from various public health frameworks, Crutchfield provides an array of values to consider, such as: utility
-
The Mystery of Mental Integrity: Clarifying Its Relevance to Neurotechnologies Neuroethics (IF 2.6) Pub Date : 2023-08-21 Hazem Zohny, David M. Lyreskog, Ilina Singh, Julian Savulescu
The concept of mental integrity is currently a significant topic in discussions concerning the regulation of neurotechnologies. Technologies such as deep brain stimulation and brain-computer interfaces are believed to pose a unique threat to mental integrity, and some authors have advocated for a legal right to protect it. Despite this, there remains uncertainty about what mental integrity entails
-
Recruitment and Engagement of Indigenous Peoples in Brain-Related Health Research Neuroethics (IF 2.6) Pub Date : 2023-08-12 Miles Schaffrick, Melissa L. Perreault, Louise Harding, Judy Illes
-
A Conceptual Framework to Safeguard the Neuroright to Personal Autonomy Neuroethics (IF 2.6) Pub Date : 2023-08-05 José M. Muñoz, Javier Bernácer, Francisco Güell
In this article, we propose a philosophical exploration on the main problems involved in two neurorights that concern autonomous action, namely free will and cognitive liberty, and sketch a possible solution to these problems by resourcing to a holistic interpretation of human actions. First, we expose the main conceptual and practical issues arising from the neuroright to “free will,” which are far
-
Hope and Optimism in Pediatric Deep Brain Stimulation: Key Stakeholder Perspectives Neuroethics (IF 2.6) Pub Date : 2023-08-01 Natalie Dorfman, Lilly Snellman, Ynez Kerley, Kristin Kostick-Quenet, Gabriel Lazaro-Munoz, Eric A. Storch, Jennifer Blumenthal-Barby
Introduction Deep brain stimulation (DBS) is utilized to treat pediatric refractory dystonia and its use in pediatric patients is expected to grow. One important question concerns the impact of hope and unrealistic optimism on decision-making, especially in “last resort” intervention scenarios such as DBS for refractory conditions. Objective This study examined stakeholder experiences and perspectives
-
Mild Cognitive Impairment in Relation to Alzheimer’s Disease: An Investigation of Principles, Classifications, Ethics, and Problems Neuroethics (IF 2.6) Pub Date : 2023-07-05 Joseph Lee
Mild Cognitive Impairment (MCI) is a diagnostic category indicating cognitive impairment which does not meet diagnostic criteria for dementia such as Alzheimer’s disease. There are public health concerns about Alzheimer’s disease (AD) prompting intervention strategies to respond to predictions about the impacts of ageing populations and cognitive decline. This relationship between MCI and AD rests
-
Revisiting Maher’s One-Factor Theory of Delusion Neuroethics (IF 2.6) Pub Date : 2023-06-06 Chenwei Nie
How many factors, i.e. departures from normality, are necessary to explain a delusion? Maher’s classic one-factor theory argues that the only factor is the patient’s anomalous experience, and a delusion arises as a normal explanation of this experience. The more recent two-factor theory, on the other hand, contends that a second factor is also needed, with reasoning abnormality being a potential candidate
-
The Role of Family Members in Psychiatric Deep Brain Stimulation Trials: More Than Psychosocial Support Neuroethics (IF 2.6) Pub Date : 2023-05-26 Marion Boulicault, Sara Goering, Eran Klein, Darin Dougherty, Alik S. Widge
Family members can provide crucial support to individuals participating in clinical trials. In research on the “newest frontier” of Deep Brain Stimulation (DBS)—the use of DBS for psychiatric conditions—family member support is frequently listed as a criterion for trial enrollment. Despite the significance of family members, qualitative ethics research on DBS for psychiatric conditions has focused
-
Normality and the Treatment-Enhancement Distinction Neuroethics (IF 2.6) Pub Date : 2023-05-22 Daniel Martín, Jon Rueda, Brian D. Earp, Ivar R. Hannikainen
-
Merging Minds: The Conceptual and Ethical Impacts of Emerging Technologies for Collective Minds Neuroethics (IF 2.6) Pub Date : 2023-03-28 David M. Lyreskog, Hazem Zohny, Julian Savulescu, Ilina Singh
-
Invasive Neurotechnology: A Study of the Concept of Invasiveness in Neuroethics Neuroethics (IF 2.6) Pub Date : 2023-03-23 Benjamin Collins, Eran Klein
-
Philosophical foundation of the right to mental integrity in the age of neurotechnologies Neuroethics (IF 2.6) Pub Date : 2023-03-22 Andrea Lavazza, Rodolfo Giorgi
Neurotechnologies broadly understood are tools that have the capability to read, record and modify our mental activity by acting on its brain correlates. The emergence of increasingly powerful and sophisticated techniques has given rise to the proposal to introduce new rights specifically directed to protect mental privacy, freedom of thought, and mental integrity. These rights, also proposed as basic
-
Neurorights as Hohfeldian Privileges Neuroethics (IF 2.6) Pub Date : 2023-01-13 Stephen Rainey
This paper argues that calls for neurorights propose an overcomplicated approach. It does this through analysis of ‘rights’ using the influential framework provided by Wesley Hohfeld, whose analytic jurisprudence is still well regarded in its clarificatory approach to discussions of rights. Having disentangled some unclarities in talk about rights, the paper proposes the idea of ‘novel human rights’
-
Mental Integrity in the Attention Economy: in Search of the Right to Attention Neuroethics (IF 2.6) Pub Date : 2022-12-30 Bartlomiej Chomanski
Is it wrong to distract? Is it wrong to direct others’ attention in ways they otherwise would not choose? If so, what are the grounds of this wrong – and, in expounding them, do we have to at once condemn large chunks of contemporary digital commerce (also known as the attention economy)? In what follows, I attempt to cast light on these questions. Specifically, I argue – following the pioneering work
-
Brain Death: Still A Puzzle After All These Years Neuroethics (IF 2.6) Pub Date : 2022-12-15 Richard Maundrell
The definition of death as “irreversible coma” was introduced in 1968 by the Harvard University Medical School. It was developed largely in diagnostic terms as the “irreversible cessation of all functions of the entire brain, including the brainstem.” In its review of brain death in 1981, The President’s Commission for the Study of Ethical Problems in Medicine argued that brain death is consonant with
-
The Ethics of Memory Modification: Personal Narratives, Relational Selves and Autonomy Neuroethics (IF 2.6) Pub Date : 2022-11-28 Przemysław Zawadzki
For nearly two decades, ethicists have expressed concerns that the further development and use of memory modification technologies (MMTs)—techniques allowing to intentionally and selectively alter memories—may threaten the very foundations of who we are, our personal identity, and thus pose a threat to our well-being, or even undermine our “humaneness.” This paper examines the potential ramifications
-
Neurorights – Do we Need New Human Rights? A Reconsideration of the Right to Freedom of Thought Neuroethics (IF 2.6) Pub Date : 2022-11-23 Nora Hertz
Progress in neurotechnology and Artificial Intelligence (AI) provides unprecedented insights into the human brain. There are increasing possibilities to influence and measure brain activity. These developments raise multifaceted ethical and legal questions. The proponents of neurorights argue in favour of introducing new human rights to protect mental processes and brain data. This article discusses
-
Neurorehabilitation of Offenders, Consent and Consequentialist Ethics Neuroethics (IF 2.6) Pub Date : 2022-11-09 Francisco Lara
The new biotechnology raises expectations for modifying human behaviour through its use. This article focuses on the ethical analysis of the not so remote possibility of rehabilitating criminals by means of neurotechnological techniques. The analysis is carried out from a synthetic position of, on the one hand, the consequentialist conception of what is right and, on the other hand, the emphasis on
-
Transcranial Direct Current Stimulation (tDCS) in Pediatric Populations—– Voices from Typically Developing Children and Adolescents and their Parents Neuroethics (IF 2.6) Pub Date : 2022-11-05 Anna Sierawska, Maike Splittgerber, Vera Moliadze, Michael Siniatchkin, Alena Buyx
Background Transcranial direct current stimulation (tDCS) is a brain stimulation technique currently being researched as an alternative or complimentary treatment for various neurological disorders. There is little knowledge about experiences of the participants of tDCS clinical research, especially from pediatric studies. Methods An interview study with typically developing minors (n = 19, mean age
-
Challenges to the Diagnosis of Functional Neurological Disorder: Feigning, Intentionality, and Responsibility Neuroethics (IF 2.6) Pub Date : 2022-10-22 Xenos L. Mason
The diagnosis of Functional Neurological Disorder (FND) requires differentiation from other neurologic diseases/syndromes, and from the comparatively rare diagnosis of feigning (Malingering and Factitious Disorder). Analyzing the process of diagnosing FND reveals a necessary element of presumption, which I propose underlies some of the uncertainty, discomfort, and stigma associated with this diagnosis